)
Avenue Therapeutics (ATXI) investor relations material
Avenue Therapeutics AGM 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
CEO Alexandra MacLean called the 2025 Annual Meeting of Stockholders to order and introduced the board members present via remote communication.
The meeting was held virtually, with instructions for stockholder participation and question submission provided.
Board and executive committee updates
Directors up for election included Jay Kranzler, Faith Charles, Neil Herskowitz, Alexandra MacLean, Curtis Oltmans, and Lindsay A. Rosenwald.
Overview of voting outcomes
A quorum was confirmed as present, allowing the meeting to proceed.
All nominated directors were elected to serve until the 2026 Annual Meeting or until successors are elected.
The appointment of KPMG LLP as independent registered public accounting firm for the 2025 fiscal year was ratified.
- All director nominees, auditor ratification, and incentive plan amendments were approved.ATXI
AGM 20243 Feb 2026 - Seeks up to $35M to fund neurologic drug pipeline amid high risk and Fortress Biotech control.ATXI
Registration Filing16 Dec 2025 - Stockholders will elect directors, ratify KPMG as auditor, and review governance and compensation.ATXI
Proxy Filing5 Dec 2025 - Net loss narrowed to $2.2M as R&D costs fell and $1.4M revenue was recognized from AnnJi deal.ATXI
Q3 202513 Nov 2025 - AJ201 trial nears topline data as net loss narrows and funding needs persist.ATXI
Q3 20249 Oct 2025 - Returned to profitability in Q2 2025 on AnnJi deal revenue, but funding risks remain.ATXI
Q2 202514 Aug 2025 - Net loss narrowed, cash increased, and clinical progress made, but more funding is needed.ATXI
Q2 202413 Jun 2025 - Net loss widened to $11.7M in 2024 amid a key license dispute and Nasdaq delisting.ATXI
Q4 202410 Jun 2025 - Q1 2025 saw narrowed losses, AJ201 exit, and urgent need for new funding post-Nasdaq delisting.ATXI
Q1 20256 Jun 2025
Next Avenue Therapeutics earnings date
Next Avenue Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)